Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from ...

The roller-coaster ride for Novartis—as it uses every bit of its legal muscle to extend Entresto's market exclusivity—took ...

A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' ...

Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals ...

By Blake Brittain WASHINGTON - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic ...

The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s ...

Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug ...

By Blake Brittain WASHINGTON - A Washington, D.C. federal judge on Wednesday refused Novartis' eleventh-hour bid to block ...

A federal judge in Washington, D.C. denied Novartis' attempt to block MSN Pharmaceuticals from launching a generic version of its top-selling heart-failure drug, Entresto. This decision allows MSN to ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision reversing a district court’s ...

Swiss pharma giant Novartis has expressed its satisfaction at a decision by the US Court of Appeals for the Federal Circuit ...

A U.S. appeals court temporarily blocked a generic version of Novartis' Entresto, and new price limits challenge pharma as ...